Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview

Fulgent Genetics

28/07/2026 21:58

Fulgent Genetics Inc FLGT.OQ FLGT.O is expected to  show a rise in quarterly revenue when it reports  results on July 30 for the period ending June 30 2026
The El Monte California-based  company is expected to report a 14.9% increase in revenue to $94 million from $81.8 million a year ago, according to the estimate from one analyst, based on LSEG data.
​LSEG's mean analyst estimate for Fulgent Genetics Inc is for a loss of 46 cents per share. 
The one available analyst rating on the shares is "hold".  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Fulgent Genetics Inc is $15.00, about 23.4% below its last closing price of $19.58
This summary was machine generated July 28 at 20:58 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)